Aggressive tumour cells share many characteristics with embryonic stem cells, contributing to the conundrum of tumour cell plasticity. This review discusses the evidence for the convergence of embryonic and tumorigenic signalling pathways, highlighting the most prominent targets that could be therapeutically beneficial.
- Mary J. C. Hendrix
- Elisabeth A. Seftor
- Lynne-Marie Postovit